FdaApplication

ANDA 212106

Back to search

Identifiers

Properties

PropertyValue
applicant_namePHARMADAX INC
application_typeANDA
approval_date2020-08-10

Products (2)

ProductActive ingredientStrengthDosage form
ENTECAVIRENTECAVIR0.5MGTABLET;ORAL
ENTECAVIRENTECAVIR1MGTABLET;ORAL

2 products